Drug-Eluting Stents Are Safe and Effective: Right or Wrong?
- 4 April 2006
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 47 (7) , 1361-1362
- https://doi.org/10.1016/j.jacc.2006.02.001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Two-Year Outcomes After Sirolimus-Eluting Stent ImplantationJournal of the American College of Cardiology, 2006
- Sirolimus-Eluting Stents Remain Superior to Bare-Metal Stents at Two YearsJournal of the American College of Cardiology, 2006
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Maintenance of Long-Term Clinical Benefit With Sirolimus-Eluting Coronary StentsCirculation, 2005
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- Endoluminal Beta-Radiation Therapy for the Prevention of Coronary Restenosis after Balloon AngioplastyNew England Journal of Medicine, 2001
- Geometric Vascular Remodeling After Balloon Angioplasty and β-Radiation TherapyCirculation, 1999
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- Coronary-Artery Stents and Other Endoluminal DevicesNew England Journal of Medicine, 1991
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987